Objectives
This new workshop is intended to promote an understanding of recent developments in advanced methods for economic evaluation to inform HTA, with a focus on cost-effectiveness analysis (CEA):
-
Critique and choose appropriate advanced methods for CEA to inform HTA
-
Identify the data requirements to inform advanced HTA methods
-
Oversee the undertaking of appropriate advanced analysis
-
Communicate advanced methods effectively to a range of decision-makers
-
Early awareness of key developing topics in economic evaluation for HTA
Intended Audience
The workshop is aimed at health technology assessment (HTA) analysts, managers and policymakers, wishing to understand the key challenges for economic evaluation to inform HTA. It offers insight into state-of-the-art analytical techniques and criteria for selecting appropriate methods, given the particular constraints and challenges of an application. The workshop is not intended to provide full acquisition of technical skills, given the large quantity of material it covers. Instead, it focuses on understanding the principles of more cutting edge methods used to inform cost-effectiveness models to support HTA. There are a number of practical exercises during the workshop designed to support an understanding of the methods covered, so we ask that you are proficient with using Microsoft Excel.
Prerequisites
In order to attend and get the most from this workshop, we recommend that you read and be familiar with 'Methods for the Economic Evaluation of Health Care Programmes' Fourth Edition (Oxford University Press) prior to attending the workshop (copies of this book can be purchased from OUP or Amazon below). If you have other training commensurate with the level of the book, this should also be fine.
Workshop Leads
From Centre for Health Economics (CHE), University of York:
Mark Sculpher
Professor and Head of Department
Mark is Professor of Health Economics and Director of the Centre for Health Economics at the University of York. He has been involved in health technology assessment and economic evaluation for 35 years including membership of NICE’s Technology Appraisal Group, Public Health Advisory Group and Diagnostic Advisory Group. He has also advised NICE and other HTA decision making bodies on economic evaluation methods.
Laura Bokje
Professor
Laura is Professor of Health Economics. She leads the Team for Economic Evaluation and Health Technology Assessment in the Centre for Health Economics at the University of York. Laura has worked in HTA and economic evaluation for nearly 25 years. She has worked across a wide range of applied and methodological projects, across Pharmacoeconomics and Public Health, in the UK and globally. Laura has contributed to technology appraisals for NICE in her role as a member of one of the independent academic groups undertaking assessments and evidence reviews and as an appraisal committee member until 2022.
Marta Soares
Professor
Marta is Professor of Health Economics in the Centre for Health Economics at the University of York. Her research focusses on the development and application of statistical, econometric and decision analysis methods in all components of health technology assessment, including statistical analysis of primary data, evidence synthesis, elicitation of expert opinion, decision modelling methods and value of further research analysis. She served as a member of the National Institute for Health and Care Excellence (NICE) Technology Appraisal Committee between 2011 and 2017 and since 2017 she acts as a pharmacoeconomic expert for INFARMED in Portugal.
Topic Leads
From Centre for Health Economics (CHE), University of York:
Karl Claxton
Professor
Karl Claxton is a Professor of Health Economics in the Centre for Health Economics, University of York. He was a founding member of the NICE Appraisal Committee in 1999 and served on various NICE Appraisal Committees until 2012. His research interests include methods for the economic evaluation of health technologies, Bayesian decision theory, innovation and pharmaceutical pricing policy.
Mike Drummond
Emeritus Professor
Mike is Emeritis Professor of Health Economics in the Centre for Health Economics, University of York. His research focusses on the economic evaluation of health care treatments and programmes and he has undertaken evaluations in a wide range of medical fields including care of the elderly, neonatal intensive care, immunization programmes, services for people with AIDS, eye health care and pharmaceuticals. He was chair of a Guideline Review Panel for the National Institute for Health and Care Excellence (NICE) in the UK and has advised several governments on the assessment of health technologies and acted as a consultant to the WHO and the EU. In 2010, he was made a member of the National Academy of Medicine in the USA, and is a former President of the International Society of Technology Assessment in Health Care and the International Society for Pharmacoeconomics and Outcomes Research. He is currently Co-Editor-in-Chief of Value in Health.
Ana Duarte
Research Fellow
Ana Duarte is a Research Fellow in the Centre for Health Economics at the University of York. Her research focuses on the application of decision analytic models to inform Health Technology Assessment (HTA). Ana has contributed extensively to the NICE technology and diagnostic appraisal programme. Her research interests include the economic evaluation of diagnostic and prognostic tests, and advanced therapy medicinal products.
David Glynn
Research Fellow
David is a Research Fellow in the Centre for Health Economics at the University of York. His research interests include: value of information methodology, Machine learning, Bayesian methods, multimorbidity modelling and meta-epidemiology.
Susan Griffin
Professor
Susan is Professor of Health Economics Fellow in the Centre for Health Economics at the University of York. She works across a range of topics in economic evaluation, public health and health technology assessment. Susan has contributed to technology appraisals for NICE, as a member of one of the independent academic groups undertaking evidence reviews, as a member of the Technology Appraisal Committee, and in the development of methods used at NICE. Her research interests include decision-analytic models, value of information analysis and the incorporation of inequality concerns into cost effectiveness analysis.
Julia Hatamyar
Research Fellow
Julia is a Research Fellow in the Centre for Health Economics at the University of York. She works in the Global Health team and focusses on the use of machine learning techniques and causal inference methods to inform health policies.
Sebastian Hinde
Senior Research Fellow
Sebastian Hinde is a Senior Research in the Centre for Health Economics at the University of York. He has conducted economic evaluations in a range of settings, most notably related to decision modelling and alongside randomised control trials, with recent applied and methodological work focussing on the role of health economics in local commissioning decisions.
Dina Jankovic
Research Fellow
Dina is a Research Fellow in the Centre for Health Economics at the University of York. She works on a range of model-based cost-effectiveness analyses and methodological research to support decision making in healthcare. Dina researched methods for structured expert elicitation as part of her PhD and has maintained her interest in the topic since she worked on the recent MRC-funded protocol for conducting SEE in healthcare decision-making and led on the development of STEER resources for conducting expert elicitation.
Natalia Kunst
Senior Research Fellow
Natalia is a Senior Research Fellow in the Centre for Health Economics at the University of York. Her research interests are in uncertainty and evidence in decision-analytic modelling, health economic evaluations, value of information analysis, and health disparities. She recently joined a NICE Technology Appraisal Committee.
Andrea Manca
Professor
Andrea is Professor of Health Economics Fellow in the Centre for Health Economics at the University of York. Andrea’s research interests focus on the application of statistical methods for the analysis of cost effectiveness and health outcomes data, as well as the use of evidence synthesis techniques for healthcare decision making. Andrea is currently a member of a NICE Technology Appraisal Committee.
Stephen Palmer
Professor
Stephen is Professor of Health Economics in the Centre for Health Economics at the University of York. He has over 30 years’ experience of health economic evaluation, regulatory and reimbursement processes and has published over 200 peer-reviewed articles. Stephen’s principal areas of expertise relate to the methodology and application of decision-analytic modelling and evidence synthesis approaches for Health Technology Assessment (HTA). Stephen previously led a programme of work between 2005 and 2019 supporting NICE technology appraisals and he was also a member of NICE’s Technology Appraisal Committee for 10 years. More recently, he has led on the development of novel HTA methods and processes for the evaluation of cell & amp, gene therapies and histology independent products.
Claire Rothery
Professor
Claire is Professor of Health Economics Fellow in the Centre for Health Economics at the University of York.
Beth Woods
Senior Research Fellow
Beth is a Senior Research Fellow in the Centre for Health Economics at the University of York. Beth has worked on economic evaluations of a range of technologies, including the application of advanced statistical and decision modelling methods. Beth has also contributed to methods in the field, in particular relating to model structuring in oncology, evaluation of pharmaceutical pricing policy, and evaluation and pricing of technologies to address antimicrobial resistance.
Helen Weatherly
Professor
Helen is a Professor in the Centre for Health Economics at the University of York. She currently works on the Unit Costs of Health and Social Care programme, as well as a number of economic evaluations and research collaborations in the UK and overseas.
Pedro Saramago
Senior Research Fellow
Pedro is a Senior Research Fellow / Associate Professor of Health Economics in the Centre for Health Economics at the University of York. His research focusses on the economic evaluation of health and care interventions, including drugs, devices, procedures, diagnostic tests and long-term care. Pedro's research interests are related to the development and application of statistical, econometric and decision analysis methods in all components of health technology assessment, including statistical analysis of primary data, evidence synthesis, decision modelling methods and value of further research analysis. Pedro is currently a member of the National Institute for Health and Care Excellence (NICE) Technology Appraisal Committee C and Vice President of the Executive Commission of Health Technology Assessment at INFARMED in Portugal.
From Centre for Reviews and Dissemination (CRD), University of York:
Sofia Dias
Professor
Sofia is a Professor in Health Technology Assessment at the Centre for Reviews and Dissemination at the University of York. She is also Director of the CRD/CHE Technology Assessment Group that delivers technology assessment reports for the National Institute for Health and Care Excellence (NICE) through York's NIHR funded TAR programme. She is a statistician with interests in Bayesian methods for evidence synthesis and their application to decision-making.
External Speakers
(may be subject to change)
Keith Abrams, Professor of Statistics & Data Science, Department of Statistics, University of Warwick, UK
Amanda Adler, Professor of Diabetic Medicine and Health Policy, and Director of Diabetes Trials Unit, University of Oxford, UK
Karen Lee, Adjunct Professor, Canadian Agency for Drugs & Technologies in Health (CADTH), University of Ottawa, Canada
Douglas Lundin, Chief Economist, The Dental and Pharmaceutical Benefits Agency (TLV), Sweden
Danny Palnoch, Head of Medicines Analysis, NHS England and NHS Improvement, UK
Steve Pearson, Founder & President, Institute for Clinical and Economic Review (ICER), USA
Stephen Smith, Vice Chair, Technology Appraisals Committee D, National Institute for Health and Care Excellence (NICE), UK
